FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034174006> ?p ?o ?g. }

• W3034174006 abstract "Introduction Recombinant factor IX Fc fusion protein (rFIXFc) has demonstrated efficacy for treatment of haemophilia B in the Phase 3 B-LONG and Kids B-LONG studies. However, long-term rFIXFc safety and efficacy data have not yet been reported. Aim To report long-term rFIXFc safety and efficacy in subjects with haemophilia B. Methods B-YOND (NCT01425723) was an open-label extension for eligibl previously treated subjects who completed B-LONG or Kids B-LONG. Subjects received ≥1 treatment regimen: weekly prophylaxis (WP), individualized interval prophylaxis (IP), modified prophylaxis or episodic treatment. Subjects could switch regimens at any time. The primary endpoint was inhibitor development. Results Ninety-three subjects from B-LONG and 27 from Kids B-LONG (aged 3-63 years) were enrolled. Most subjects received WP (B-LONG: n = 51; Kids B-LONG: n = 23). For subjects from B-LONG, median (range) treatment duration was 4.0 (0.3-5.4) years and median (range) number of exposure days (EDs) was 146 (8-462) EDs. Corresponding values for paediatric subjects were 2.6 (0.2-3.9) years and 132 (50-256) EDs. No inhibitors were observed (0 per 1000 subject-years; 95% confidence interval, 0-8.9) and the overall rFIXFc safety profile was consistent with prior studies. Annualized bleed rates remained low and extended-dosing intervals were maintained for most subjects. Median dosing interval for the IP group was approximately 14 days for adults and adolescents (n = 31) and 10 days for paediatric subjects (n = 5). Conclusions B-YOND results confirm the long-term (up to 5 years, with cumulative duration up to 6.5 years) well-characterized safety and efficacy of rFIXFc treatment for haemophilia B." @default.
• W3034174006 created "2020-06-12" @default.
• W3034174006 creator A5012955594 @default.
• W3034174006 creator A5019518672 @default.
• W3034174006 creator A5027136982 @default.
• W3034174006 creator A5033744481 @default.
• W3034174006 creator A5034890002 @default.
• W3034174006 creator A5037461534 @default.
• W3034174006 creator A5038597185 @default.
• W3034174006 creator A5039329053 @default.
• W3034174006 creator A5047434427 @default.
• W3034174006 creator A5056910106 @default.
• W3034174006 creator A5058639047 @default.
• W3034174006 creator A5069063909 @default.
• W3034174006 creator A5070826588 @default.
• W3034174006 creator A5071519850 @default.
• W3034174006 creator A5075720694 @default.
• W3034174006 creator A5081987561 @default.
• W3034174006 creator A5087552786 @default.
• W3034174006 date "2020-06-04" @default.
• W3034174006 modified "2023-10-06" @default.
• W3034174006 title "Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study" @default.
• W3034174006 cites W1754890660 @default.
• W3034174006 cites W1964898159 @default.
• W3034174006 cites W1976624075 @default.
• W3034174006 cites W1985872523 @default.
• W3034174006 cites W1997085090 @default.
• W3034174006 cites W2004211552 @default.
• W3034174006 cites W2005719363 @default.
• W3034174006 cites W2007881102 @default.
• W3034174006 cites W2009052421 @default.
• W3034174006 cites W2013607072 @default.
• W3034174006 cites W2040982285 @default.
• W3034174006 cites W2075409267 @default.
• W3034174006 cites W2088316192 @default.
• W3034174006 cites W2099134690 @default.
• W3034174006 cites W2167801052 @default.
• W3034174006 cites W2291672567 @default.
• W3034174006 cites W2293939513 @default.
• W3034174006 cites W2516950901 @default.
• W3034174006 cites W2561075414 @default.
• W3034174006 cites W2584559805 @default.
• W3034174006 cites W2597779110 @default.
• W3034174006 cites W2792468493 @default.
• W3034174006 cites W2807217137 @default.
• W3034174006 cites W2808973643 @default.
• W3034174006 cites W2891041376 @default.
• W3034174006 cites W2895694705 @default.
• W3034174006 cites W4226255158 @default.
• W3034174006 cites W4379377935 @default.
• W3034174006 doi "https://doi.org/10.1111/hae.14036" @default.
• W3034174006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32497409" @default.
• W3034174006 hasPublicationYear "2020" @default.
• W3034174006 type Work @default.
• W3034174006 sameAs 3034174006 @default.
• W3034174006 citedByCount "26" @default.
• W3034174006 countsByYear W30341740062020 @default.
• W3034174006 countsByYear W30341740062021 @default.
• W3034174006 countsByYear W30341740062022 @default.
• W3034174006 countsByYear W30341740062023 @default.
• W3034174006 crossrefType "journal-article" @default.
• W3034174006 hasAuthorship W3034174006A5012955594 @default.
• W3034174006 hasAuthorship W3034174006A5019518672 @default.
• W3034174006 hasAuthorship W3034174006A5027136982 @default.
• W3034174006 hasAuthorship W3034174006A5033744481 @default.
• W3034174006 hasAuthorship W3034174006A5034890002 @default.
• W3034174006 hasAuthorship W3034174006A5037461534 @default.
• W3034174006 hasAuthorship W3034174006A5038597185 @default.
• W3034174006 hasAuthorship W3034174006A5039329053 @default.
• W3034174006 hasAuthorship W3034174006A5047434427 @default.
• W3034174006 hasAuthorship W3034174006A5056910106 @default.
• W3034174006 hasAuthorship W3034174006A5058639047 @default.
• W3034174006 hasAuthorship W3034174006A5069063909 @default.
• W3034174006 hasAuthorship W3034174006A5070826588 @default.
• W3034174006 hasAuthorship W3034174006A5071519850 @default.
• W3034174006 hasAuthorship W3034174006A5075720694 @default.
• W3034174006 hasAuthorship W3034174006A5081987561 @default.
• W3034174006 hasAuthorship W3034174006A5087552786 @default.
• W3034174006 hasBestOaLocation W30341740061 @default.
• W3034174006 hasConcept C126322002 @default.
• W3034174006 hasConcept C187212893 @default.
• W3034174006 hasConcept C203092338 @default.
• W3034174006 hasConcept C2777081929 @default.
• W3034174006 hasConcept C2777232031 @default.
• W3034174006 hasConcept C2777288759 @default.
• W3034174006 hasConcept C2777785397 @default.
• W3034174006 hasConcept C2778385053 @default.
• W3034174006 hasConcept C2781221834 @default.
• W3034174006 hasConcept C2781413609 @default.
• W3034174006 hasConcept C44249647 @default.
• W3034174006 hasConcept C535046627 @default.
• W3034174006 hasConcept C71924100 @default.
• W3034174006 hasConceptScore W3034174006C126322002 @default.
• W3034174006 hasConceptScore W3034174006C187212893 @default.
• W3034174006 hasConceptScore W3034174006C203092338 @default.
• W3034174006 hasConceptScore W3034174006C2777081929 @default.
• W3034174006 hasConceptScore W3034174006C2777232031 @default.
• W3034174006 hasConceptScore W3034174006C2777288759 @default.
• W3034174006 hasConceptScore W3034174006C2777785397 @default.
• W3034174006 hasConceptScore W3034174006C2778385053 @default.

• next